Brian T. Powl

CIK: 0001934232

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)11 (73.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (26.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

KURA

Kura Oncology, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (15 total)

KURA
Kura Oncology, Inc.
Sep 29, 2026
Sale(S)
Direct
15.4K shares at avg. $10.75$166K
KURA
Kura Oncology, Inc.
Sep 28, 2026
Sale(S)
Direct
9K shares at avg. $10.50$95K
KURA
Kura Oncology, Inc.
Sep 28, 2026
Sale(S)
Direct
8K shares at avg. $10.56$84K
KURA
Kura Oncology, Inc.
Aug 21, 2026
Sale(S)
Direct
4.3K shares at avg. $11.89$52K
KURA
Kura Oncology, Inc.
May 21, 2026
Sale(S)
Direct
10K shares at avg. $11.00$110K
KURA
Kura Oncology, Inc.
May 19, 2026
Sale(S)
Direct
339 shares at avg. $9.21$3K
KURA
Kura Oncology, Inc.
Jan 27, 2026
Sale(S)
Direct
1.6K shares at avg. $8.46$13K
KURA
Kura Oncology, Inc.
Jan 27, 2026
Sale(S)
Direct
4.8K shares at avg. $8.46$41K
KURA
Kura Oncology, Inc.
Jan 2, 2026
Award(A)
Direct
50K shares-
KURA
Kura Oncology, Inc.
Nov 14, 2025
Sale(S)
Direct
8.9K shares at avg. $11.18$99K
KURA
Kura Oncology, Inc.
Nov 13, 2025
Award(A)
Direct
48.9K shares-
KURA
Kura Oncology, Inc.
Sep 29, 2025
Sale(S)
Direct
8.9K shares at avg. $8.94$80K
KURA
Kura Oncology, Inc.
Sep 27, 2025
Award(A)
Direct
48.9K shares-
KURA
Kura Oncology, Inc.
Jan 28, 2025
Sale(S)
Direct
1.6K shares at avg. $7.87$12K
KURA
Kura Oncology, Inc.
Jan 2, 2025
Award(A)
Direct
46.3K shares-

		Type	Shares	Price		Ownership
Sep 29, 2026	KURA Kura Oncology, Inc.	Sale(S)	15,430	$10.75	$165,852	Direct
Sep 28, 2026	KURA Kura Oncology, Inc.	Sale(S)	9,020	$10.50	$94,686	Direct
Sep 28, 2026	KURA Kura Oncology, Inc.	Sale(S)	8,000	$10.56	$84,498	Direct
Aug 21, 2026	KURA Kura Oncology, Inc.	Sale(S)	4,345	$11.89	$51,663	Direct
May 21, 2026	KURA Kura Oncology, Inc.	Sale(S)	10,000	$11.00	$110,000	Direct
May 19, 2026	KURA Kura Oncology, Inc.	Sale(S)	339	$9.21	$3,122	Direct
Jan 27, 2026	KURA Kura Oncology, Inc.	Sale(S)	1,572	$8.46	$13,300	Direct
Jan 27, 2026	KURA Kura Oncology, Inc.	Sale(S)	4,842	$8.46	$40,966	Direct
Jan 2, 2026	KURA Kura Oncology, Inc.	Award(A)	50,000	-	$0	Direct
Nov 14, 2025	KURA Kura Oncology, Inc.	Sale(S)	8,887	$11.18	$99,329	Direct
Nov 13, 2025	KURA Kura Oncology, Inc.	Award(A)	48,900	-	-	Direct
Sep 29, 2025	KURA Kura Oncology, Inc.	Sale(S)	8,891	$8.94	$79,505	Direct
Sep 27, 2025	KURA Kura Oncology, Inc.	Award(A)	48,900	-	-	Direct
Jan 28, 2025	KURA Kura Oncology, Inc.	Sale(S)	1,583	$7.87	$12,461	Direct
Jan 2, 2025	KURA Kura Oncology, Inc.	Award(A)	46,250	-	$0	Direct

1-15 of 15 transactions

About Powl Brian T.

Powl Brian T. (SEC CIK 0001934232) files insider reports with the SEC as Chief Commercial Officer of Kura Oncology, Inc. (KURA).

Signal8 holds 10 ownership filings by Powl Brian T., all Form 4s, filed between Jan 6, 2025 and Sep 29, 2026. Those filings report 15 transactions, from Jan 2, 2025 to Sep 29, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Powl Brian T.'s filings is in SAN DIEGO, CA.

Recent filings by Powl Brian T.

Sep 29, 2026: Open-market sale of KURA shares (Form 4, code S).
Sep 28, 2026: Open-market sales of KURA shares (2 lines, Form 4, code S).
Aug 21, 2026: Open-market sale of KURA shares (Form 4, code S).
May 21, 2026: Open-market sale of KURA shares (Form 4, code S).
May 19, 2026: Open-market sale of KURA shares (Form 4, code S).

Other insiders filing for Kura Oncology, Inc. (KURA)

Bair Teresa Brophy, Chief Legal Officer
FORD KATHLEEN, Chief Operating Officer
Leoni Mollie, Chief Medical Officer
DOYLE THOMAS JAMES, SVP, Finance & Accounting
Burrows Francis, Chief Scientific Officer
Fulk Jennifer, Chief Financial Officer

How to read Form 4 transaction codes